• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合团体教育对降低慢性肾脏病患者体重、尿酸水平和利尿剂使用的疗效:一项回顾性研究。

Efficacy of comprehensive group-based education in lowering body weight, uric acid levels, and diuretic use in patients with chronic kidney disease: a retrospective study.

机构信息

Department of Nursing, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

Department of Nephrology, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.

出版信息

BMC Nephrol. 2023 Sep 14;24(1):272. doi: 10.1186/s12882-023-03293-0.

DOI:10.1186/s12882-023-03293-0
PMID:37710146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10503079/
Abstract

BACKGROUND

Patient education for the management of chronic kidney disease (CKD) is attracting attention. Therefore, this study aimed to analyze changes in body weight, uric acid, and estimated-glomerular filtration rate (eGFR) in patients with CKD after a group-based education during admission.

METHODS

Overall, 157 patients with CKD, who were discharged from the nephrology department of our hospital between January 2015 and October 2019, received group-based education or individual-based education by nurses at admission. Deltas of body weight, uric acid, and eGFR, 6 months from baseline, were compared between group- and individual-based education using the Wilcoxon rank sum test.

RESULTS

In total, 60 patients receiving group-based education (G group, n =35) or individual-based education (I group, n =25) during admission were included in this retrospective study. The patient characteristics at baseline were as follows: age mean, 72 ± SD 9; 16 females and 44 males; body weight, 62 ± 17 kg; eGFR median, 21 (IQR: 14, 29) mL/min/1.73 m; UA, 7 (6.1, 7.5) mg/dL; and estimated intake of salt 6.9 (6.2, 8.4) g/day. Delta eGFR (mL/min/1.73 m) was -1 (-3, 3) for G group and -1 (-2.5, 2) for I group (p = 0.8039). Delta body weight (kg) was -0.4 (-1.6, 0) for G group and 0 (-0.45, 0.95) for I group (p = 0.0597). Delta uric acid (mg/dL) was -1.1 (-1.6, 0.1) for G group and -0.2 (-1.1, 0.5) for I group (p = 0.0567). In patients with higher sodium intake (≥ 117.4 mEq/day), delta body weight was significantly lower in the group-based education group than in the individual-based education group (p = 0.0398).

CONCLUSIONS

A comprehensive group-based education in patients with CKD may effectively suppress body weight and uric acid in 6 months along with less frequent diuretic use.

摘要

背景

患者的慢性肾脏病(CKD)管理教育正受到关注。因此,本研究旨在分析入院时接受基于小组的教育后,CKD 患者的体重、尿酸和估算肾小球滤过率(eGFR)的变化。

方法

本研究共纳入 2015 年 1 月至 2019 年 10 月期间从我院肾病科出院的 157 例 CKD 患者,入院时护士对患者进行基于小组或基于个体的教育。使用 Wilcoxon 秩和检验比较组间和个体间教育后 6 个月时体重、尿酸和 eGFR 的变化。

结果

共纳入 60 例患者,他们在入院时接受基于小组的教育(G 组,n=35)或基于个体的教育(I 组,n=25)。入组时患者的特征如下:年龄平均为 72 ± 9 岁;女性 16 例,男性 44 例;体重 62 ± 17kg;eGFR 中位数为 21(IQR:14,29)mL/min/1.73m;UA 为 7(6.1,7.5)mg/dL;估计盐摄入量为 6.9(6.2,8.4)g/天。G 组的 eGFR 变化(mL/min/1.73m)为-1(-3,3),I 组为-1(-2.5,2)(p=0.8039)。G 组体重变化(kg)为-0.4(-1.6,0),I 组为 0(-0.45,0.95)(p=0.0597)。G 组尿酸变化(mg/dL)为-1.1(-1.6,0.1),I 组为-0.2(-1.1,0.5)(p=0.0567)。在钠摄入量较高(≥117.4mEq/天)的患者中,基于小组的教育组的体重变化明显低于基于个体的教育组(p=0.0398)。

结论

CKD 患者的综合小组教育可能会在 6 个月内有效抑制体重和尿酸,同时减少利尿剂的使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/4abe9511ccd8/12882_2023_3293_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/f21522bc4d96/12882_2023_3293_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/e542ae8eba99/12882_2023_3293_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/73887e106603/12882_2023_3293_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/b65fef3f6fb8/12882_2023_3293_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/6aa6def52aca/12882_2023_3293_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/4abe9511ccd8/12882_2023_3293_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/f21522bc4d96/12882_2023_3293_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/e542ae8eba99/12882_2023_3293_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/73887e106603/12882_2023_3293_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/b65fef3f6fb8/12882_2023_3293_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/6aa6def52aca/12882_2023_3293_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0f/10503079/4abe9511ccd8/12882_2023_3293_Fig6_HTML.jpg

相似文献

1
Efficacy of comprehensive group-based education in lowering body weight, uric acid levels, and diuretic use in patients with chronic kidney disease: a retrospective study.综合团体教育对降低慢性肾脏病患者体重、尿酸水平和利尿剂使用的疗效:一项回顾性研究。
BMC Nephrol. 2023 Sep 14;24(1):272. doi: 10.1186/s12882-023-03293-0.
2
Uric acid and incident chronic kidney disease in dyslipidemic individuals.尿酸与血脂异常个体中的慢性肾脏病事件。
Curr Med Res Opin. 2018 Jul;34(7):1193-1199. doi: 10.1080/03007995.2017.1372157. Epub 2017 Sep 21.
3
The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial.高尿酸血症与伴有血脂异常的慢性肾脏病患者肾功能的相关性:ASUCA 试验的一项亚组分析。
Clin Exp Nephrol. 2020 May;24(5):420-426. doi: 10.1007/s10157-019-01840-4. Epub 2019 Dec 26.
4
Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.在一组转诊的III期、IV期和V期慢性肾脏病患者中,尿酸与肾功能下降或开始肾脏替代治疗的时间无关。
Nephrol Dial Transplant. 2015 Dec;30(12):2039-45. doi: 10.1093/ndt/gfv225. Epub 2015 Jul 16.
5
The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis.多尼尿酸对高尿酸血症合并慢性肾脏病 4-5 期患者尿酸及肾功能的疗效和安全性:一项单中心回顾性分析。
Drug Des Devel Ther. 2023 Nov 3;17:3233-3248. doi: 10.2147/DDDT.S416025. eCollection 2023.
6
Association of Uric Acid-Lowering Therapy With Incident Chronic Kidney Disease.降尿酸治疗与慢性肾脏病事件的关联。
JAMA Netw Open. 2022 Jun 1;5(6):e2215878. doi: 10.1001/jamanetworkopen.2022.15878.
7
Uric Acid Control in Advanced Chronic Kidney Disease in a Southeastern US Urban Cohort.美国东南部城市队列中晚期慢性肾病的尿酸控制
South Med J. 2018 Sep;111(9):549-555. doi: 10.14423/SMJ.0000000000000862.
8
The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.血清尿酸降低对慢性肾脏病高尿酸血症患者肾功能和血压的影响。
Clin Exp Nephrol. 2018 Dec;22(6):1300-1308. doi: 10.1007/s10157-018-1580-4. Epub 2018 Apr 26.
9
A formula predicting the effective dose of febuxostat in chronic kidney disease patients with asymptomatic hyperuricemia based on a retrospective study and a validation cohort
.一项基于回顾性研究和验证队列的预测非布司他在无症状高尿酸血症慢性肾病患者中有效剂量的公式。
Clin Nephrol. 2020 Aug;94(2):61-69. doi: 10.5414/CN109867.
10
Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.儿童和青少年高尿酸血症与慢性肾脏病进展:儿童慢性肾脏病(CKiD)队列研究
Am J Kidney Dis. 2015 Dec;66(6):984-92. doi: 10.1053/j.ajkd.2015.06.015. Epub 2015 Jul 21.

本文引用的文献

1
A systematic review and meta-analysis of the association between uric acid levels and chronic kidney disease.尿酸水平与慢性肾脏病相关性的系统评价和荟萃分析。
Sci Rep. 2022 Apr 15;12(1):6251. doi: 10.1038/s41598-022-10118-x.
2
A Formula for the Estimation of 24-Hour Urinary Creatinine Excretion: A Derivation and Validation Study.一种估算24小时尿肌酐排泄量的公式:推导与验证研究。
J Ren Nutr. 2022 Mar;32(2):214-223. doi: 10.1053/j.jrn.2021.05.002. Epub 2021 Aug 13.
3
Altered dietary salt intake for people with chronic kidney disease.
改变慢性肾脏病患者的饮食盐摄入量。
Cochrane Database Syst Rev. 2021 Jun 24;6(6):CD010070. doi: 10.1002/14651858.CD010070.pub3.
4
Group-Based Care in Adults and Adolescents With Hypertension and CKD: A Feasibility Study.高血压和慢性肾脏病成人及青少年的群组式照护:一项可行性研究
Kidney Med. 2020 Apr 18;2(3):317-325. doi: 10.1016/j.xkme.2020.01.013. eCollection 2020 May-Jun.
5
Augmented Nurse Care Management in CKD Stages 4 to 5: A Randomized Trial.CKD 4 至 5 期的强化护士护理管理:一项随机试验。
Am J Kidney Dis. 2017 Oct;70(4):498-505. doi: 10.1053/j.ajkd.2017.02.366. Epub 2017 Apr 7.
6
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.在有和没有高血压的个体中,尿钠排泄与心血管事件的关联:四项研究数据的汇总分析。
Lancet. 2016 Jul 30;388(10043):465-75. doi: 10.1016/S0140-6736(16)30467-6. Epub 2016 May 20.
7
Educational Interventions for Patients With CKD: A Systematic Review.慢性肾脏病患者的教育干预:系统评价。
Am J Kidney Dis. 2016 Sep;68(3):353-70. doi: 10.1053/j.ajkd.2016.01.022. Epub 2016 Mar 26.
8
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care.向患者宣传慢性肾脏病:自我管理和以患者为中心的医疗之路。
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):694-703. doi: 10.2215/CJN.07680715. Epub 2015 Nov 4.
9
Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.强化低盐饮食教育对接受奥美沙坦治疗的非糖尿病高血压患者蛋白尿的影响:一项单盲随机对照试验。
Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2059-69. doi: 10.2215/CJN.01310214. Epub 2014 Oct 20.
10
High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.高钠摄入量与一大群慢性肾病患者的重要风险因素相关。
Eur J Clin Nutr. 2015 Jul;69(7):786-90. doi: 10.1038/ejcn.2014.215. Epub 2014 Oct 8.